These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 9925072)
21. [Therapy with nasal CPAP (continuous positive airway pressure) in patients with obstructive sleep apnea syndrome (OSAS). I: Long-term acceptance of nasal CPAP]. Hollandt JH; Kuhl S; Siegert R Laryngorhinootologie; 1997 Sep; 76(9):550-3. PubMed ID: 9417184 [TBL] [Abstract][Full Text] [Related]
22. Obstructive sleep apnea in infants and its management with nasal continuous positive airway pressure. McNamara F; Sullivan CE Chest; 1999 Jul; 116(1):10-6. PubMed ID: 10424497 [TBL] [Abstract][Full Text] [Related]
23. The effect of positive reinforcement on hourly compliance in nasal continuous positive airway pressure users with obstructive sleep apnea. Fletcher EC; Luckett RA Am Rev Respir Dis; 1991 May; 143(5 Pt 1):936-41. PubMed ID: 2024846 [TBL] [Abstract][Full Text] [Related]
24. Breathing during sleep in patients treated for obstructive sleep apnea. Nasal CPAP for only part of the night. Rauscher H; Popp W; Wanke T; Zwick H Chest; 1991 Jul; 100(1):156-9. PubMed ID: 2060335 [TBL] [Abstract][Full Text] [Related]
31. Automated continuous positive airway pressure titration for obstructive sleep apnea syndrome. Teschler H; Berthon-Jones M; Thompson AB; Henkel A; Henry J; Konietzko N Am J Respir Crit Care Med; 1996 Sep; 154(3 Pt 1):734-40. PubMed ID: 8810613 [TBL] [Abstract][Full Text] [Related]
32. Mouth breathing in obstructive sleep apnea prior to and during nasal continuous positive airway pressure. Ruhle KH; Nilius G Respiration; 2008; 76(1):40-5. PubMed ID: 18042974 [TBL] [Abstract][Full Text] [Related]
33. NCPAP for the treatment of obstructive sleep apnea. Silva AB; Lemmi H Arq Neuropsiquiatr; 1989 Jun; 47(2):150-2. PubMed ID: 2688605 [TBL] [Abstract][Full Text] [Related]
34. Significant improvement of olfactory performance in sleep apnea patients after three months of nasal CPAP therapy - Observational study and randomized trial. Boerner B; Tini GM; Fachinger P; Graber SM; Irani S PLoS One; 2017; 12(2):e0171087. PubMed ID: 28158212 [TBL] [Abstract][Full Text] [Related]
35. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091 [TBL] [Abstract][Full Text] [Related]
36. [Diagnostic findings in patients with obstructive sleep apnea syndrome in nCPAP therapy]. Fietze I; Warmuth R; Quispe-Bravo S; Reglin B Pneumologie; 1993 Mar; 47 Suppl 1():170-4. PubMed ID: 8497473 [TBL] [Abstract][Full Text] [Related]
38. Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airway pressure on simulated steering performance in patients with obstructive sleep apnoea. Hack M; Davies RJ; Mullins R; Choi SJ; Ramdassingh-Dow S; Jenkinson C; Stradling JR Thorax; 2000 Mar; 55(3):224-31. PubMed ID: 10679542 [TBL] [Abstract][Full Text] [Related]
39. Effect of 12-month nasal continuous positive airway pressure therapy for obstructive sleep apnea on progression of chronic kidney disease. Li X; Liu C; Zhang H; Zhang J; Zhao M; Sun D; Xia M; Han M Medicine (Baltimore); 2019 Feb; 98(8):e14545. PubMed ID: 30813163 [TBL] [Abstract][Full Text] [Related]
40. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Black JE; Hirshkowitz M Sleep; 2005 Apr; 28(4):464-71. PubMed ID: 16171291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]